Measurement of self-advocacy in cancer patients and survivors.
BACKGROUND
The Patient Self-Advocacy Scale, originally developed for use in HIV/AIDS patients, was adapted for use in cancer patients and survivors. The scale contains three dimensions: increased illness education, increased assertiveness with a doctor, and potential for mindful non-adherence.


CONCLUSIONS
Evidence for modest reliability and construct validity was found; however, ceiling effects exist for the Illness Education subscale, which supports the need to move beyond items regarding information seeking to perhaps include use and management of information.
Hermansen-Kobulnicky
Carol J
CJ
University of Wyoming School of Pharmacy, 1000 E. University Avenue, Dept 3375, Laramie, WY 82071-3375, USA. cjhkobul@uwyo.edu
D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000534:rehabilitation*; D010344:Patient Advocacy; D015203:Reproducibility of Results; D012648:Self Care; D011795:Surveys and Questionnaires; D017741:Survivors; D014481:United States